Philip Morris (PM) closed at $95.33 in the latest trading session, marking a +1.12% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.63%. On the other hand, the Dow registered a gain of 0.2%, and the technology-centric Nasdaq increased by 0.82%.The seller of Marlboro and other cigarette brands's stock has climbed by 5.15% in the past month, exceeding the Consumer Staples sector's gain of 1.73% and the S&P 500's gain of 1.76%.Market participants will be closely following the financia ...

Philip Morris International Inc. (PM) is going all the way to accelerate its smoke-free transformation. With the ambition of generating more than two-thirds of its total revenues from smoke-free products by 2030, Philip Morris aims to offer enhanced alternatives to consumers. Moving on these lines, the company has unveiled its latest offering, the IQOS ILUMA i. The launch coincides with the 10-year anniversary of IQOS, which was initially introduced in Nagoya, Japan, in 2014.This new addition to Philip Morr ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced the launch of IQOS ILUMA i, the latest and most innovative addition to its growing portfolio of smoke-free products for adults who would otherwise continue to smoke or use nicotine products. Today, this range of better alternatives to cigarettes includes multiple generations of IQOS, the No. 1 tobacco heating system.1 The launch also marks the 10-Year anniversary of IQOS, originally launching in Nagoya, ...

Philip Morris (PM) closed the most recent trading day at $94.67, moving +0.28% from the previous trading session. This change lagged the S&P 500's 1.12% gain on the day. Meanwhile, the Dow experienced a rise of 0.61%, and the technology-dominated Nasdaq saw an increase of 1.54%.Prior to today's trading, shares of the seller of Marlboro and other cigarette brands had gained 4.9% over the past month. This has outpaced the Consumer Staples sector's gain of 1.98% and the S&P 500's gain of 2.06% in that time.Ana ...

STAMFORD, CT--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.30 per common share, payable on April 9, 2024, to shareholders of record as of March 21, 2024. The ex-dividend date is March 20, 2024. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international ...

STAMFORD, Conn.--(BUSINESS WIRE)--Today, Philip Morris International (PMI) (NYSE: PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women’s Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. Beginning January 2025, in coordination with WBDC, PMI’s U.S. business will c ...

The most recent trading session ended with Philip Morris (PM) standing at $89.96, reflecting a -0.51% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.52%. Elsewhere, the Dow saw an upswing of 0.12%, while the tech-heavy Nasdaq appreciated by 0.9%.Shares of the seller of Marlboro and other cigarette brands have depreciated by 0.47% over the course of the past month, underperforming the Consumer Staples sector's gain of 1.34% and the S&P 500's gain of 3.85%.Inv ...

Philip Morris (PM) ended the recent trading session at $91.56, demonstrating a +0.41% swing from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.04%. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq lost 0.28%.Heading into today, shares of the seller of Marlboro and other cigarette brands had lost 0.02% over the past month, lagging the Consumer Staples sector's gain of 3.75% and the S&P 500's gain of 5.01% in that time.The investment community will be paying c ...

Philip Morris International Inc. (NYSE:PM) Consumer Analyst Group of New York (CAGNY) Conference February 21, 2024 10:00 AM ET Company Participants Jacek Olczak - Chief Executive Officer Emmanuel Babeau - Chief Financial Officer Stacy Kennedy - President of Americas & CEO of PMI U.S. Stefano Volpetti - President, Smoke-Free Inhaled Products & Chief Consumer Officer Conference Call Participants Bonnie Herzog - Goldman Sachs Bonnie Herzog And thanks again for joining us today. So it's my pleasure to welcome P ...

Financial Forecast and Performance - The company reaffirms its 2024 full-year reported diluted EPS forecast of $5.90 to $6.02, representing a currency-neutral increase of 7% to 9% compared to the adjusted diluted EPS of $6.01 in 2023 [2] - Adjustments for 2024 include asset impairment, termination costs, tax impacts, and other items totaling $0.42 per share, with an additional unfavorable currency impact of $0.11 per share [2][3] - Adjusted diluted EPS for 2024 is projected to be $6.32 to $6.44, excluding adjustments and currency impacts [3] Smoke-Free Transformation and Product Portfolio - The company is progressing towards becoming a substantially smoke-free business by 2030, with smoke-free products accounting for approximately 37% of total full-year 2023 net revenues [3][8] - PMI has invested $12.5 billion since 2008 to develop and commercialize smoke-free products, aiming to end cigarette sales [8] - As of December 31, 2023, PMI's smoke-free products were available in 84 markets, with an estimated 20.8 million adults having switched to IQOS and stopped smoking [8] - The company's multi-category portfolio includes leading premium brands in heat-not-burn and oral nicotine, such as IQOS and ZYN [3][8] Strategic Initiatives and Acquisitions - PMI completed the acquisition of Swedish Match in 2022, creating a global smoke-free champion with a focus on oral nicotine delivery [8] - The company is conducting a strategic review of the U.S. cigar business as part of its integration efforts with Swedish Match [3] - PMI aims to expand into wellness and healthcare areas through its Vectura Fertin Pharma business, leveraging its expertise in life sciences [8] Market and Regulatory Environment - The U.S. Food and Drug Administration has authorized versions of PMI's IQOS Platform 1 devices and Swedish Match's General snus as Modified Risk Tobacco Products [8] - The company faces challenges such as excise tax increases, regulatory restrictions, and health concerns related to tobacco and nicotine products [6] - PMI is subject to risks from global economic, regulatory, and political developments, as well as the impact of conflicts like Russia's invasion of Ukraine [6]